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Lumpy Skin Disease (LSD) is an emerging disease of cattle that causes substantial
economic loss to affected regions. However, factors favouring transmission under
field conditions and farm-level impacts are poorly quantified. This was a retrospective
case-control study of cattle farms in Nakuru, Kenya to determine risk factors associated
with lumpy skin disease and the farm-level economic impacts of an outbreak. Data were
collected using questionnaires administered through personal interview. Collected data
included herd sizes, age, and sex structures, breeds, sources of replacement stock,
grazing systems, and costs (direct and indirect) incurred when LSD outbreaks occurred.
Farm-level risk factors were examined through univariable and multivariable logistic
regression and a final model built using backward stepwise regression and likelihood
ratio tests. The factors associated with LSD outbreaks on univariable analysis included
breed (exotic vs. indigenous, OR = 15.01, P = 0.007), source of replacement stock
(outside the herd vs. within the herd, OR = 8.38, P < 0.001) and herd size (large [>10
cattle] vs. small [1–3 cattle], OR= 3.51, P= 0.029). In the multivariable logistic regression
model, only breed (exotic vs. indigenous, OR = 14.87, 95% CI 1.94–113.97, P = 0.009)
and source of replacement stock (outside the herd vs. within the herd OR = 8.7, 95%
CI 2.80–27.0, P < 0.001) were associated with outbreaks. The economic impact was
compared between farms keeping purely indigenous (n = 10) or exotic (n = 29) breeds
of cattle which indicated mean farm-level losses of 12,431 KSH/123 USD and 76,297
KSH/755 USD, respectively. The mean farm-level losses from reduction in milk yield and
mortality were estimated at 4,725 KSH/97 USD and 3,103 KSH/31USD for farms keeping
indigenous breeds whilst for farms keeping exotic breeds the equivalent losses were
26,886 KSH/266 USD and 43,557 KSH/431 USD, respectively. The indirect losses from
treatments and vaccinations were proportionately much higher on farms with indigenous
breeds at 4,603 KSH/46 USD making up ∼37% of the total costs compared to ∼8%
(5,855 KSH/58 USD per farm) of the total costs for farms with exotic breeds. These
findings indicate that LSD caused significant economic losses at the farm level in Nakuru
County. This justifies implementation of disease control measures including quarantine of
cattle post-purchase and the need for effective vaccinations of susceptible cattle herds.
Keywords: economic impact, risk factors, lumpy skin disease, case-control study, vaccine
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INTRODUCTION
Lumpy skin disease (LSD) is caused by the poxvirus lumpy
skin disease virus in genus Capripoxvirus that also includes the
closely related sheeppox virus and goatpox virus (1–3). Cattle
are the predominant species affected although infection has also
been reported in water buffalo (4, 5). Historically, the virus was
restricted to the African continent with sporadic incursions into
the Middle East, but since 2012 the disease has spread in easterly
and westerly directions as far as the Balkans and Kazakhstan
(6, 7).
There have been several other studies of LSD in the region
particularly in Ethiopia. In West Wolega, Zelalem et al. (8)
estimated individual and herd-level seroprevalence of 6.4 and
6.0%, respectively. Their study demonstrated relatively higher
seroprevalence in older animals and in Bos taurus compared to
Bos indicus cattle. Also in Ethiopia, it was reported that disease
burden was lower in highland compared to mid- and lowland
areas possibly related to the relative abundance of biting fly
populations (9–11). Communal grazing and watering has also
been associated with a higher occurrence of LSD, likely due to the
increased opportunity for mechanical transmission of the virus
by Stomoxys spp. and mosquitoes (Aedes aegypti) (9, 12, 13).
In Zimbabwe, higher LSD was associated with the proximity
to game parks suggesting the wildlife-cattle interface may be
important for transmission (14). Numerous wildlife hosts have
been suspected including the African Cape Buffalo (15, 16).
Transhumance and other reasons for animal movements has also
been associated with an increased risk of outbreaks (17, 18).
Clinical signs of LSD include the appearance of raised, circular,
firm, coalescing nodules on the skin which can develop cores
of necrotic material called “sit-fasts” (19). Lumpy Skin Disease
virus (LSDV) is thought to be primarily transmitted by biting and
blood feeding arthropods that include species from the Glossina,
Muscidae, and Tabanidae families, in addition to some species of
hard tick (11, 20–23, 23–26). Virus transmission through direct
contact has been reported but this is considered an inefficient
route (27–29). LSD is a listed disease according to the World
Animal Health Organization (OIE) due to the potential for rapid
spread of virus in susceptible cattle populations and the severe
economic consequences it causes in affected herds (30).
In the event of an incursion into a previously LSDV-
free country, control measures may include strict quarantine,
restriction of animal movements, reactive vaccination, isolation
and slaughter of affected animals, proper disposal of carcasses,
cleaning and disinfection of the premises and insect control
Abbreviations: GCRF, Global Challenges Research Fund; BBSRC, Biotechnology
and Biological Sciences Research Council; FAO, Food and Agriculture
organization of the United Nations; KNBS, Kenya National Bureau of Statistics;
LSD, Lumpy Skin Disease; AU-IBAR, African Union Inter-African Bureau
for Animal Resources; EFSA, European Food Safety Authority; OIE, World
Organization for Animal Health; CFSPH, Centre for Food Security and Public
Health; SCVO, Subcounty Veterinary Officer; STATA, Data Analysis and Statistical
Software; AI, Artificial Insemination; Ksh., Kenya Shillings; USD, United States
of America Dollars; CI, Confidence Interval; OR, Odds Ratio; LSDV, Lumpy Skin
Disease Virus; GALVmed, Global Alliance for Livestock Veterinary Medicines;
MS, Microsoft; LRT, Likelihood Ratio Tests; FVM, Faculty of Veterinary Medicine;
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(11, 29, 31). Occasionally, whole herd depopulation has been
recommended, but in endemic scenarios the affected farms
often isolate sick animals and provide supportive treatment
that may include wound dressings to prevent fly infestations
and secondary infections (11, 29). Vaccination may also be
used with both reactive and routine strategies being employed.
Most currently available vaccines are live attenuated and contain
either LSDV (homologous) or sheep and goat pox strains
(heterologous) (11, 31). Heterologous vaccines are generally
considered to be less effective but with fewer side effects
particularly in European breeds of cattle (32).
It has been proposed that the control of LSD is likely to
enhance the livelihoods of farmers and others dependent on
livestock (33). Although LSD outbreaks are generally associated
with lower morbidity and mortality rates in herds when
compared to some other OIE listed livestock diseases, the
economic consequences of the outbreak results from prolonged
loss of production in both dairy and beef cattle through loss of
weight in diseased cattle, and loss of traction for farms using cattle
as a source of draught power (11, 34). Other types of direct losses
may include reduced quality of hides and meat, reduced milk
yield in affected herds, culling of affected animals, and infertility
secondary to severe orchitis (2, 11, 35). Indirect losses are either
from additional costs of disease control or the value of foregone
revenue. Additional costs may be from vaccines, vaccine delivery,
movement controls, use of diagnostic tests, and culling animals
while the value of foregone revenue include use of sub-optimal
breeds and denied access to both local and international markets
(36). Studies estimating farm-level losses due to LSD outbreaks
in endemic settings are lacking in the literature although a recent
study in Ethiopia estimated the median total economic loss
of an LSD outbreak at herd level to be USD 1,176 with the
largest component due tomortality followed by reduction inmilk
output (37).
Lumpy Skin Disease is endemic throughout East Africa and
was first described in Kenya in 1957 (38). Since then, LSD
epidemics have been reported irregularly in various parts of
Kenya (39). Despite the assumed importance of disease, no
studies have been published describing the risk factors associated
with its occurrence at the farm level and the economic costs
incurred by livestock keepers in Kenya. These studies are essential
for informing control strategies and allocating limited resources
for livestock disease control at a farm and national level. The
aim of this study was to determine the risk factors for LSD
outbreak through a matched case-control study and to estimate
the economic impact on affected farms.
MATERIALS AND METHODS
Study Area and Population
The study was undertaken in Nakuru County, Kenya, an area
of 7,495 km² with 11 administrative Sub-counties (Figure 1).
According to the previous national census, the County was
the fourth most populous in the country with ∼1.6 million
people. The same census revealed a livestock population of
439,994 cattle, 505,035 sheep, and 227,037 goats (40). There
are a variety of production systems present in Nakuru County
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including pastoralism, intensive, and semi-intensive. Pastoralists
were not included in this study due to their extensive movements
making retrospective assessments of risk factors and choice
of controls extremely challenging. The eligible population for
inclusion in this study was all sedentary cattle herds present in the
County between September 2016 and October 2017. The county
was selected due to a pre-existing network of collaborators,
frequent reports of disease and the importance of cattle in the
farming systems.
Study Design and Sample Size
Determination
The study utilised an individual-matched case-control approach
due to the reported low incidence of disease based on local
expert opinion. The sampling units were households that kept
cattle. Potential case farms were initially identified through
discussions with Sub-county Veterinary Officers (SCVOs) and
their staff including a review of written records of attended cases
and rumoured outbreaks. Subsequent case herds were identified
through discussion with local animal health practitioners and
farmers affected with disease. Unaffected households (controls)
were selected by assigning all non-case households in the same
village with a unique identification number and randomly
selecting until the desired number of control households was
reached. The sample size was estimated using the epiR (version
0.9-99) package in R3.5.2 based on the methodology described
by Dupont (41) in 1988 (Equation 1). This used the following
equation to estimate the sample size for frequency matched case
control studies:
N=
(
zβv
1
2
ϕ+z α
2
v
1
2
1
)2
(
e1−eϕ
)2
(1)
ψ = Odds ratio for exposure in case and controls.
v= Variance
e= Exponent
Z=Number of standard deviations from the data point mean
α = Type I error probability
β = Type II error probability
N = Number of cases
To optimise the efficiency of the study, four controls were
matched for each case. Based on the assumption of 20% controls
having a risk factor of interest, in order to have 80% power
to detect an odds ratio (OR) of 3.0 with 95% confidence, 41
cases and 164 controls were required. This calculation assumed
a moderate correlation in exposures between case and control
exposures (rho= 0.2).
Case and Control Definitions
Case herds were defined based on clinical suspicion of LSD
in at least one bovine demonstrating the characteristic clinical
sign of raised, circular, firm, nodules varying from 1 to 7 cm in
diameter (11, 29, 42). Case farms were eligible for recruitment
if the suspected case occurred between September 2016 and
October 2017. Laboratory confirmation was not readily available,
so case farms were based on clinical suspicions only. Matching
criteria for control herds were based within the same village
and not reporting suspected LSD between September 2016 and
October 2017.
Data Collection
Primary data were collected on household-level herd structures
and putative risk factors for LSD between October 2017
and February 2018. Household-level risk factors were chosen
based on those described in the literature and included
breed, introduction of new animals, vaccination status against
LSD (pre-LSD outbreak and post-LSD outbreak vaccination
was recorded and confirmed with the sub-county veterinary
department), and management practices that encouraged inter-
herd contact (including using communal grazing and watering
points, mixing in post-harvest fields, communal dipping for
acaricide administration, and breeding system). A questionnaire
was created and administered using KoboCollect R© mobile phone
application. The questionnaire was piloted with five households
in September 2017 to detect any questions that could be
ambiguous. Apart from questions on direct and indirect losses
from case households, the questionnaire was identical for case
and control herds and is available as Supplementary Material to
this manuscript.
The economic impact was estimated based on the framework
described by Rushton et al. (36), where direct losses are incurred
through reduction on level of production and indirect losses
incurred through reactions to disease occurrence either by
treatment or application of prevention measures. Direct losses
were estimated from the increased number of cattle mortalities
and reduced milk production in affected cattle herds, while
indirect losses were estimated from the costs incurred on
preventive vaccination and treatment of sick cattle. The cost of
cattle mortality considered the number, age, and sex of those
affected herds, and prices of livestock and their products were
obtained from various livestock markets and farms breeding
cattle for sale. Furthermore, this information from the farmers
was verified with local animal health providers who attended
to the cases. Losses in milk were estimated from the reduction
in level of milk production and duration a herd remained with
clinical disease as reported by the interviewed farmers. The cost
of vaccination was based on the fees (Ksh) households were
charged for vaccinating their cattle against LSD (which may
or may not have been subsidised by the County government).
While treatment costs were based on the fees (Ksh) charged
on households for treatment of clinical cases of LSD including
the purchase price for antibiotics and other transactional costs
including consultation and transport charges by the animal
health services provider.
Data Management and Analysis
Data were downloaded from KoboCollect R© mobile application
and exported to MS Excel R© 2010 prior to analysis using
Stata 13 R© (StataCorp, College Station, TX, USA). The data
analysis involved estimating descriptive statistical measures and
inferential statistics.
Logistic regression was used to generate odds ratios and
estimate the strength of evidence at the household-level between
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FIGURE 1 | Map of Kenya showing the location of Nakuru County and 11 Sub-counties.
putative risk factors and having at least one case of LSD. All
models included the matching variable (village) as a fixed effect.
Variables associated on univariable logistic regression analysis
(at P ≤ 0.2) were taken forward for possible inclusion in a
multivariable model. This conservative P-value was used in the
univariable analysis to include as many variables as possible in
the multivariable analysis. The final multivariable model was
built using a backward stepwise approach and likelihood ratio
tests (LRT) to compare models with and without each of the
variables. Variables were retained if the P-value of the LRT was
≤0.05. Interaction between variables in the final model was
tested using LRTs and the presence of collinearity was tested by
estimating variance inflation factors. The economic losses were
compared between farms keeping indigenous and exotic breeds
using unpaired t-tests. The approach used by Jemberu et al. (43)
in estimation of economic impact of Foot and Mouth Disease
and by Molla et al. (37) in estimation of economic impact of
LSD in Ethiopia was adopted in the analysis of the estimated
economic losses.
The economic cost of LSD vaccination was calculated as;
Vacostij = NVa
∗
i PVai (2)
Where,
Vacostij = the vaccination cost for affected herd i with breed j
(without consideration of subsidy if any);
NVai = the number of animals vaccinated;
PVai = the mean per head expenditure on LSD vaccination
(whether prior or post LSD);
The economic cost of LSD treatment was calculated as;
TrCostij = NTr
∗
i PTri (3)
Where,
TrCostij = the treatment cost for affected herd i with breed j;
NTri = the number of animals treated;
PTri = the mean per head expenditure to LSD treatment;
Economic losses due to milk loss per LSD affected herd were
calculated as;
Lmilkij = Ncow
∗
i Q
∗
i Tmilk
∗
i Pmilkj (4)
Where,
Lmilkij = economic losses due to milk loss for herd i with
breed j;
Ncowi = number of lactating cows affected in herd i;
Qi =mean quantity of milk lost in liters per affected herd per
day in herd i;
Tmilki =mean duration of illness in days of affected lactating
cows in herd i,
Pmilkj = mean selling price of milk per litre reported by
farmers in herd i. The economic loss due to mortality per herd
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was calculated as
Lmortij =
(
Nmortfcalf∗i Pfcalf
)
+
(
Nmortmcalf∗i Pmcalf
)
+
(
Nmortheif∗i Pheif
)
+
(
Nmortbull∗i Pbull
)
+
(
Nmortlact∗i Plact
)
+
(
Nmortdry∗i Pdry
)
(5)
Where,
Lmortij = economic losses due to mortality for a herd i with
breed j;
Nmortfcalfi = number of female calves died in herd i;
Pfcalf= price of a female calf;
Nmortmcalfi = number of male calves died in herd i;
Pmcalf= price of a male calf;
Nmortheifi = number of heifers died in herd i;
Pheif= price of a heifer;
Nmortbulli = number of bulls died in herd i;
Pbull= price of a bull;
Nmortlacti = number of lactating cows died in herd i;
Plact= price of a lactating cow;
Nmortdryi = number of dry cows died in herd i;
Pdry= price of a dry cow;
Total economic losses per herd were aggregated as the sum of
all losses arising from milk loss, mortality, cost of treatment and
cost of vaccination.
TELij = Vacost
∗
ij TrCost
∗
ij Milk
∗
ij Mortij (6)
Where,
TELij= total economic losses for herd i in a farm with breed j,
The mean economic loss per head of cattle was obtained by
dividing the herd-level economic losses by the total number of
cattle in the herd. The mean of each of the economic losses per
affected herd was obtained by dividing the specific economic
losses in the herd by the total number of herds affected.
All KSH to USD conversion rates are the yearly means as
per the central bank of Kenya forex rates (available at https://
www.centralbank.go.ke/rates/forex-exchange-rates/) for the year
in which a study was conducted.
Ethical approval for the study was obtained through the
Biosafety, Animal Care and Use committee within the Faculty
of Veterinary Medicine at the University of Nairobi, Kenya
(Reference number FVM BAUEC/2018/171).
RESULTS
Characteristics of the Study Farms
Of the 11 sub-counties in Nakuru County, one (Rongai) reported
cases during the study period with the others reporting cases
prior to the study inclusion dates. A total of 41 case farms and
164 control farms were visited in six villages of Rongai sub-
county. The majority (165/205, 80.5%) of respondents were the
farm owners. Other respondents were farm managers (17.1%) or
other family members (2.4%) of the farm owner such as the wife
and children. The mean herd sizes in both case and control farms
was eight (range 1–69). In the case farms, the mean herd size
was 11 (range 2–59) while in the control farms was 7 (range 1–
69). This comprised of a mean herd size of 10.6 (range 1–59) for
indigenous breeds of cattle and 5.6 (range 1–36) for exotic breeds
of cattle.
The distribution of potential risk factors for LSD outbreaks
in case and control herds is presented in Table 1. Based on
univariable analysis, there was good statistical evidence that
compared to non-affected control herds, case herds tended to
consist of exotic (i.e., European) breeds (OR = 15.01, 95% CI
2.09–108.04), be larger in size (OR = 3.51, 95% CI 1.14–10.83),
and source replacement cattle from outside the farm (OR =
8.38, 95% CI 2.93–23.92) as shown in Table 1. There was weak
statistical evidence that case farms tended to use rivers as a
communal water source (OR = 3.40, 95% CI 0.83–13.84), and
use a communal dip as opposed to spraying at home for tick
control (OR= 3.71, 95% CI 0.80–17.29). There was no statistical
evidence of any difference in grazing system (OR = 2.88, 95%
CI 0.31–26.74) and vaccination status (OR = 1.52, 95% CI
0.49–4.71) in case and control herds.
The multivariable analysis included all variables in the
univariable models that had a P-value <0.2. Backward fitting
of the model using likelihood ratio tests and an inclusion cut-
off of <0.05 led to two variables being retained in the final
model. Farms with LSD were significantly more likely to source
replacement cattle from outside the herd (outside sourced vs.
own farm sourced OR = 8.7; 2.8–27.0, P < 0.01) and to consist
entirely of exotic breeds (indigenous breed vs. exotic breed herds
OR= 0.06; 0.01–0.52, P = 0.01) (Table 2). The result of variance
inflation factors analysis showed moderate collinearity between
breed and village which was included in all models as a fixed
effect. However, dropping the breed variable from the model did
not significantly affect the association between LSD status and the
source of replacement cattle.
On the farmers’ knowledge of the disease, most of the farmers
(n = 108, 78.8%) did not have any understanding of the reasons
for LSD occurring on their farm. The remaining farmers believed
the reasons were mixing of affected cattle with unaffected ones
during roadside grazing (n = 6, 4.4%), spread by the wind
(n= 5, 3.7%), spread by biting flies (n = 5, 3.7%), spread from
the initial case that occurred in the area (n= 3, 2.2%), pastoralist
cattle from Narok county in search of pasture (n = 2, 1.5%), and
cattle passing through the area from Loruk in Baringo and Pokot
Counties being taken for sale in Marigat, Mogotio, Nakuru, and
Kenya Meat Commission within Nakuru county (n= 1, 0.7%) .
Estimated Economic Impact of Lumpy Skin
Disease in a Herd
Comparisons on the economic cost of LSD was compared
in herds consisting of purely indigenous (n = 10) or exotic
(n= 29) breeds of cattle. Two herds had mixed breeds and
were excluded from the economic analysis). Considering direct
costs, the reduction in milk production during LSD outbreaks
was estimated at a mean of 1.5 l (Range 0–4) per farm per
day for farms keeping indigenous cattle and 9.9 l (Range 0–
35 l) per farm per day for farms keeping exotic breeds of cattle
(P = 0.06). Based on an estimated duration of milk reduction
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TABLE 1 | Univariable analysis of household-level putative risk factors for Lumpy Skin Disease in Nakuru County, Kenya.
Variable Category Cases (n) %c Control (n) %d OR 95% CI P-value
Breed Exotic 29 71 102 62 15.01 2.09 108.04 0.01
Indigenous 10 24 59 36 Reference – – –
Mixed 2 5 3 2 15.50 0.03 1.39 172.83
Cattle herd size (categorical) Small (1–3) 11 27 61 37 Reference – – –
Medium (4–9) 15 37 67 41 1.76 0.67 4.64 0.25
Large (≥10) 15 37 36 22 3.51 1.14 10.83 0.03
Cattle herd size (continuous) 41 20 164 80 1.05 1.01 1.09 0.02
Dipping system Home spraying 37 90 155 97 Reference – – –
Community dip 4 10 5 3 3.71 0.80 17.29 0.01
Breeding system AI or own bulla 24 59 97 60 Reference – – –
Shared bull 17 42 66 41 1.11 0.40 2.36 0.84
LSD vaccinationb Yes 5 12 15 9 1.52 0.49 4.71 0.47
No 36 88 149 91 Reference – – –
Replacement cattle From own herd 30 73 157 96 Reference
From outside 11 27 7 4 8.38 2.93 23.92 <0.01
Watering system In rivers 11 27 29 18 3.40 0.83 13.84 0.09
Communal dams 4 10 38 23 1.25 0.34 4.55 0.74
Communal boreholes 0 0 1 1 1.00 – – –
Piped and harvested water 26 63 96 59 Reference – – –
Grazing system Tethering 1 2 9 56 Reference – – –
Zero-grazing 30 73 118 72 2.60 0.31 21.94 0.38
Free-range 10 24 37 23 2.88 0.31 26.74 0.35
Odds ratios estimated using logistic regression. Reference categories are based on the largest category size except for “herd size” where the reference is the smallest farm size (1–3
cattle). AI, Artificial insemination; OR, odds ratio; CI, confidence interval.
a AI and own bull was combined as only 2.4% (4/164) of the control farms used own bull.
b LSD vaccination between January 2016 and October 2017.
c Calculation of the cases percentage = number of observations in that variable level divided by the total number of cases, which was 41.
d Calculation of the controls percentage = number of observations in that variable level divided by the total number of controls, which was 164.
TABLE 2 | Multivariable analysis of the risk factors of Lumpy Skin Disease Outbreaks in Nakuru County.
Variable Category Case (n) % Control (n) % OR 95% CI P-value
Replacement cattle From own herd 30 73 157 96 Reference – –
From outside 11 27 7 43 8.70 2.80 26.98 <0.01
Breed Exotic breeds 29 71 102 62 14.87 1.94 113.97 0.01
Indigenous 10 24 59 36 Reference – –
Mixed breeds 2 5 3 2 7.05 0.52 95.98 0.14
Village was the matching variable and included in the model as a fixed effect.
of 70 days as reported in Ethiopia (37), this was equivalent to
a mean total loss of 4,725 KSH/47 USD ranging from 2,520
to 10,080 KSH/25–100 USD milk reduction loss per farm for
those keeping indigenous breeds of cattle. In comparison, the
estimated mean total loss due to reduced milk production
on farms keeping exotic breeds of cattle was 26,886 KSH/266
USD ranging from 2,520 to 88,200 KSH/25–873 USD (P =
0.15) as shown in Figure 2 and Table 3. The per head of
cattle loss was equivalent to a mean loss of 831 KSH/8 USD
(range 0–3,780 KSH/37 USD) and 6,440 KSH/64 USD (range
0–88,200 KSH/0–873 USD) for indigenous and exotic breeds
of cattle respectively (P = 0.33) as shown in Figure 3 and
Table 4.
The mean cost of cattle mortalities during LSD outbreaks was
estimated at 3,103 KSH/31 USD (range 180–6,026 KSH/2–60
USD) per farm keeping indigenous breeds and 43,557 KSH/431
USD (range 3,000–63,900 KSH/30–633 USD) per farm keeping
exotic breeds (P = 0.04) as shown in Figure 2 and Table 3.
The equivalent on a per affected animal basis was 55 KSH/0.5
USD (8–102 KSH/0.1–1 USD) for farms having indigenous cattle
and 9,485 KSH/94 USD (range 500–19,133 KSH/5–189 USD)
for farms having exotic breeds of cattle (P = 0.11) (Figure 3,
Table 4).
The indirect costs incurred for treatment of clinically affected
cattle in farms keeping indigenous cattle was estimated at a
mean of 3,715 KSH/37 USD compared to 5,003 KSH/50 USD for
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FIGURE 2 | Comparison of the economic impact of Lumpy Skin Disease outbreaks between farms with only indigenous breeds vs. farms with only exotic breeds in
Nakuru County, Kenya.
farms keeping exotic breeds (P = 0.30). The cost of vaccination
against LSD per farm was estimated at 1,117 KSH/11 USD
and 178 KSH/2 USD for indigenous (n = 5) and exotic (n
= 8) farms, respectively, that vaccinated cattle before the LSD
outbreak (P= 0.07) and 888 KSH/9USD and 852 KSH/8 USD for
farms with indigenous and exotic breeds of cattle, respectively,
for reactive vaccination (P = 0.96) (Figure 2, Table 3). The
preventive vaccination in farms with indigenous breeds was
higher than those of the farms with exotic breeds owing to the
relatively larger herd sizes in the farms with indigenous breeds.
The costs of treatment per animal was 691 KSH/7 USD (range
50–4,000 KSH/0.5–40 USD) for indigenous breeds of cattle and
2,442 KSH/24 USD (range 150–12,000 KSH/1–119 USD) for
exotic breeds of cattle (Figure 2, Table 3). Vaccination costs per
animal were 42 KSH/0.4 USD (range 30–50 KSH/0.3–0.5 USD)
for indigenous breeds of cattle and 65 KSH/0.6 USD (range 20–
120/0.2–1.1 USD) for exotic breeds of cattle (Figure 3, Table 4).
Based on these estimates, the overall mean loss due to LSD
for farms keeping indigenous cattle was estimated at 12,431
KSH/123 USD compared to 76,297 KSH/755 USD for farms
keeping exotic breeds of cattle. The analysis indicated that farms
keeping indigenous breeds of cattle incurred huge costs through
milk and mortality losses respectively, yet they could have been
prevented through implementing preventive vaccination. This
would have cost approximately a mean of 521 KSH/5 USD per
herd with savings amounting to 4,204 KSH/42 USD for farms
keeping indigenous breeds of cattle and 43,036 KSH/426 USD
for farms keeping exotic breeds of cattle assuming the vaccine is
100% effective. This level of savings in farms could be reallocated
to other disease control efforts within these farms.
DISCUSSION
The results of this study revealed that smallholder farms in
Nakuru County, Kenya, are at an increased risk of LSD if they
own exotic breeds of cattle and if they source their replacement
animals from outside the herd. Economic losses from LSD
were also greater in exotic cattle than in indigenous cattle. An
assessment of the overall economic impact of LSD on affected
farms indicated that those owning exotic breeds of cattle had
a higher impact at 76,297 KSH/755 USD compared to those
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TABLE 3 | Losses incurred by farms due to LSD outbreak in Nakuru County (1USD=101KSH; two farms having mixed breeds were excluded in this analysis) per farm.
Losses Item of loss Number of farms
affected
Mean cost
(KSH)
Standard
deviation
Minimum
cost (KSH)
Maximum
cost (KSH)
Direct losses Mortality losses per affected
indigenous cattle farm
2 3,103 4,134 180 6,026
Mortality losses per affected
exotic cattle farm
7 43,557 21,651 3,000 63,900
Milk losses per affected
indigenous cattle farm
4 4,725 3,619 2,520 10,080
Milk losses per affected
exotic cattle farm
13 26,886 28,876 2,520 88,200
Indirect losses Cost of treatment of LSD in
indigenous case farms
8 3,715 5,572 250 17,100
Cost of treatment of LSD in
exotic case farms
29 5,003 6,120 400 32,000
Cost of vaccination of LSD
in indigenous case farms
7 888 1,160 270 3,500
Cost of vaccination of LSD
farms with exotic breeds
13 852 1,732 90 6,480
FIGURE 3 | Comparison of the economic impact of Lumpy Skin Disease outbreaks between indigenous and exotic breeds of cattle in Nakuru County, Kenya.
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TABLE 4 | Losses incurred by farms due to LSD outbreak in Nakuru County (1 USD = 101 KSH; two farms having mixed breeds were excluded in this analysis) per head
of cattle.
Losses Item of loss Number of
animals affected
Mean cost
(KSH)
Standard
Deviation
Minimum cost
(KSH)
Maximum cost
(KSH)
Direct losses Mortality losses per affected
indigenous cattle
2 55 66 8 102
Mortality losses per affected
exotic cattle
7 9,485 6,953 500 19,133
Milk losses per affected
indigenous cow
9 831 1,318 0 3,780
Milk losses per affected
exotic cow
29 6,440 16,693 0 88,200
Indirect losses Cost of treatment of LSD in
indigenous case farms
43 691 638 50 4,000
Cost of treatment of LSD in
exotic case farms
59 2,442 2,604 150 12,000
Cost of vaccination of LSD
in indigenous case farms
132 42 9 30 50
Cost of vaccination of LSD
farms with exotic breeds
131 65 39 20 120
owning just indigenous cattle at 12,431 KSH/123 USD. On both
exotic and indigenous breed farms, most of the losses were direct
from reduced production.
The results from this study indicate that herds with indigenous
cattle were at lower risk of disease compared to those with exotic
breeds. Differences in management practices could partly explain
this observation and residual confounding cannot be discounted.
However, there are numerous reports that indigenous (i.e., Bos
indicus) cattle appear to be at a lower risk and to have less
severe clinical signs compared to exotic breeds. This includes
the findings of Khalafalla et al. (44) who observed more
severe clinical signs of LSD in exotic cattle in Sudan. In this
context, exotic (i.e., Bos taurus) breeds are mainly based on
Holstein-Friesian and occasional Jersey, Ayrshire, or Guernsey
genetics. The relative increased susceptibility of exotic breeds
has been reported for several diseases endemic to East Africa
including foot-and-mouth disease (45), theileriosis (46, 47), and
tuberculosis (48). The reason for this is likely genetic with
differences in the innate immune responses between these species
(49). In the case of LSD, it is unknown if the incidence of
infection varies between species and if subclinical infection is
more common in indigenous breeds which would require further
studies either in experimental or field settings. There could
also be differences in the susceptibility to ectoparasites that
spread infection (50). The indigenous breeds of cattle may have
the benefit of prolonged periods of natural selection favoring
individuals with greater resistance to local diseases although this
may not be relevant for LSD which was first recognized in Kenya
in 1957 (38) which is not far from the time exotic breeds were
introduced into Kenya in 1902 (51, 52).
Obtaining replacement stock from outside the farm was
associated with an increased risk of LSD. This is in accordance
with studies from Ethiopia (9) and Europe (16). This association
is likely due to introduction of virus through infected animals
that may have been within the incubation period of the disease
and thus not showing clinical signs, subclinically infected or
demonstrating clinical signs and purchased at a reduced price.
Practices that encourage mixing of cattle such as communal
grazing and watering, were not significantly associated with LSD
outbreaks which is consistent with observations by Zelalem et al.
(8) in the West Wolega zone of Ethiopia but in contrast to the
study by Gari et al. (9). These differences may have been due to
other differences in herd management and study designs.
Animal movements for reasons of trade and searching for
pasture and water during the dry season is also considered
to be a risk factor of LSD (17, 18). These aspects were not
investigated in the current study which focussed on sedentary
herds. Although most of the farmers did not have any
understanding of the reasons for LSD occurring on their farm,
some farmers believed that the reasons were mixing of affected
cattle with unaffected ones during roadside grazing, spread by
the wind, spread by biting flies, direct spread from the initial
case that occurred in the area, cattle being introduced from
other parts of the country and pastoralist cattle in search of
pasture. Movements of pastoralist herds in Nakuru County is
common and they are frequently blamed for introducing other
diseases such as foot-and-mouth disease (53) which can create
conflict between communities. Their role should be investigated,
and measures designed to reduce any associated impacts from
these movements such as enhanced surveillance strategies and
ensuring quality vaccines are available to herds at high risk
of exposure.
There were some instances when vaccinated farms reported
disease and there was no observed difference in the odds of
vaccination between case and control herds indicating limited
effectiveness against disease. However, this observation should
be treated with caution as detailed vaccination history was not
available, and the study was neither powered nor designed
to measure this effect. Using standardised terminology from
vaccine studies in humans, vaccine effectiveness compares the
incidence of an outcome between vaccinated and non-vaccinated
groups as measured under programme conditions adjusted for
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exposure risk (54). This differs from vaccine efficacy which
is measured under ideal conditions usually in the form of a
randomised controlled trial. Case-control or cohort approaches
can be used to measure vaccine effectiveness with the former
preferred in situations where the outcome incidence is low (55).
For LSD, vaccines are either based on LSD virus (homologous)
or sheep and goat pox viruses (heterologous). Various efficacy
studies mainly based on small-scale challenge studies have
been published which generally indicate homologous vaccines
confer higher rates of protection compared to heterologous
although one study provided some evidence of comparable
efficacy using the Gorgan goat pox strain (56, 57). Analysis of the
recent LSD outbreak in Europe in 2014–2018 provided evidence
that vaccination programmes based on the Neethling strain of
LSDV were very effective at controlling the disease (32, 58).
A randomised field trial in Israel also demonstrated relative
superior efficacy of the homologous vaccine (59). The vaccine
available in Kenya was previously believed to be heterologous
although molecular studies revealed it to be a homologous virus
and there have been numerous reports of poor efficacy and
effectiveness (56, 57, 60). Rigorously designed field effectiveness
studies should be prioritised and suboptimal performance
thoroughly investigated so that limited resources allocated by
farmers and governments to LSD control are appropriately used.
The economic impact of LSD in this study was higher for
farms with only exotic cattle compared to indigenous cattle.
This is consistent with the findings from a recent study from
Ethiopia (37) where it was found that the mortality loss, which
is a major contribution to financial loss, was higher in exotic
crossbreeds compared to the local breeds. For herds with exotic
breeds, the higher direct costs are ascribed to higher losses due to
reduced milk production and higher mortality. The same study
from Ethiopia also revealed these to be the largest components
of economic loss due to LSD on affected farms. This is consistent
with the previously mentioned studies highlighting the greater
severity of disease in exotic breeds. In a study of constraints
of cattle production in pastoral areas, where indigenous breeds
predominate (61), LSD was found to be a disease with low
score for impact on livelihoods (5%) and low incidence (3%). It
was ranked eighth among the 13 prevalent diseases in pastoral
areas (62).
Milk production due to LSD dropped from amean of 11.9 and
4.0 l per farm per day to 2.0 and 2.5 l per farm per day, an 83.2
and 37.5% drop for farms keeping exotic and indigenous cattle,
respectively. In a study conducted in Ethiopia, milk reduction
was by 5 l per cow per day (60). In another study in Kenya, milk
production dropped by more than 50% attributed to fever and
general sickness in both indigenous and exotic breeds who were
found to be equally susceptible to the disease (17). The losses
are higher in more severe cases of disease which appears more
likely in exotic breeds which has been attributed to their relatively
thin skin compared to the thick-skinned indigenous breeds (63).
Treatment costs were higher at the individual animal level for
exotic breeds which could be due to higher required doses of
medicines from a greater liveweight, but also faster recovery in
indigenous cattle. There may also be a tendency of herds owning
exotic breeds to seek advice and receive visits from animal health
service providers compared to those owing indigenous breeds
that may tend to deal with diseases themselves and purchase
medicines over the counter. Secondary bacterial infection is
responsible for most of the illness and loss of production in herds
indicating a possible role for antimicrobials (17) although their
prudent use is fundamental due to issues with anti-microbial
resistance and may not be necessary particularly in indigenous
breeds. This suggests a study assessing the efficacy of different
treatment protocols for LSD would be worthwhile and to the
authors’ knowledge has not been previously published.
There are numerous limitations to this study that should be
highlighted. A major limitation was the lack of reliable farm-
level data which were based on farmer interviews and like other
businessmen, farmers may have the tendency to exaggerate their
losses. Additionally, as with all case-control studies, there was
possible bias from control selection although efforts were made
to ensure this was random. Selection bias may also exist from
under-reporting of disease. With the study being retrospective, it
was not possible to establish causality while recall bias, whereby
people interviewed on case and control herds remember events
differently, cannot be ruled out or quantified. Ideally, incident
cases and confirmation of cases is recommended, but available
resources did not allow such data to be collected. Therefore,
any reported associations should be treated with caution. For
the economic analysis, the focus was just on direct losses
from mortality and milk production, and indirect losses from
treatment and vaccines. There are numerous other impacts that
were not quantified such as the impact on growth rates, fertility,
or changes in herd structure (64) so the estimates presented in
this study are likely to be lower than the true economic cost.
From a study that was carried out to estimate the returns from
smallholder dairy farming in Nakuru, it was reported that the net
returns per litre of milk produced was 3.6 KSH/0.05 USD (65).
Therefore, both the direct and indirect costs incurred by cattle
producers due to occurrence of LSD within their herds would
reduce this level of net benefits from dairy farming.
In conclusion, the results of this study indicate that farms with
exotic breeds of cattle and sourcing of replacement stock from
outside are the major risk factors for spread and maintenance
of LSD in the Nakuru county. Although vaccines were not
associated with a reduced incidence of disease, further studies
are required to more rigorously evaluate their effectiveness and
also the potential benefits of other control measures such as post-
purchase quarantine. The relatively high impact among herds
owning exotic breeds indicates that these herds would benefit
more from ensuing the availability of quality vaccines and access
to appropriate medications. These findings could be used as
the basis for developing extension materials to train farmers
and animal health service providers as well as supporting the
allocation of resources by the veterinary authorities responsible
for disease control in Nakuru County.
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